232 related articles for article (PubMed ID: 19596975)
1. Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.
Matsuda G; Kunisaki C; Makino H; Fukahori M; Kimura J; Sato T; Oshima T; Nagano Y; Fuii S; Takagawa R; Kosaka T; Ono HA; Akiyama H; Ichikawa Y
Anticancer Res; 2009 Jul; 29(7):2863-7. PubMed ID: 19596975
[TBL] [Abstract][Full Text] [Related]
2. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
Kodera Y; Ito S; Mochizuki Y; Fujitake S; Koshikawa K; Kanyama Y; Matsui T; Kojima H; Takase T; Ohashi N; Fujiwara M; Sakamoto J; Akimasa N;
Anticancer Res; 2007; 27(4C):2667-71. PubMed ID: 17695430
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma].
Ito S; Kodera Y; Mochizuki Y; Yamamura Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1427-30. PubMed ID: 16227742
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
6. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
[TBL] [Abstract][Full Text] [Related]
10. Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.
Camps C; Caballero C; Blasco A; Safont MJ; Berrocal A; Garde J; Juarez A; Sirera R; Bremnes RM
Anticancer Res; 2005; 25(6C):4611-4. PubMed ID: 16334151
[TBL] [Abstract][Full Text] [Related]
11. A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status.
Im CK; Rha SY; Jeung HC; Jeong J; Lee SH; Noh SH; Roh JK; Chung HC
Oncology; 2009; 77(6):349-57. PubMed ID: 20016228
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
[TBL] [Abstract][Full Text] [Related]
13. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
[TBL] [Abstract][Full Text] [Related]
15. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.
Scott LC; Yao JC; Benson AB; Thomas AL; Falk S; Mena RR; Picus J; Wright J; Mulcahy MF; Ajani JA; Evans TR
Cancer Chemother Pharmacol; 2009 Jan; 63(2):363-70. PubMed ID: 18398613
[TBL] [Abstract][Full Text] [Related]
17. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
[TBL] [Abstract][Full Text] [Related]
18. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
Yamamoto N; Tsurutani J; Yoshimura N; Asai G; Moriyama A; Nakagawa K; Kudoh S; Takada M; Minato Y; Fukuoka M
Anticancer Res; 2006; 26(1B):777-81. PubMed ID: 16739353
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J
Breast Cancer Res Treat; 2008 Mar; 108(2):241-50. PubMed ID: 17476588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
